Georgios Gakis1, Dorothea Weckermann2. 1. Klinik und Poliklinik für Urologie und Kinderurologie, Universitätsklinikum Würzburg, Würzburg, Deutschland. 2. Klinik für Urologie, Universitätsklinikum Augsburg, Stenglinstr. 2, 86156, Augsburg, Deutschland. dorothea.weckermann@uk-augsburg.de.
Abstract
BACKGROUND AND OBJECTIVES: Although the incidence of bladder cancer among women is lower, they tend to more often have advanced disease at presentation with a more aggressive course. It is still unclear which factors are responsible for the poorer prognosis of bladder cancer in women. MATERIALS AND METHODS: Original papers and reviews from 2004 until 2022 were identified in a PubMed search and evaluated. RESULTS: Multiple factors are likely responsible for the different courses of bladder cancer in women versus men. In the literature, epidemiologic and clinical aspects are discussed. Furthermore, genetic and hormonal causes and the role of the urobiome have been the focus of discussion more recently. CONCLUSIONS: Earlier diagnosis and better surgical treatment could lead to a more favorable course of bladder cancer in women. Further analyses of genetic, hormonal, und microbiological factors could open new perspectives in the prevention, diagnosis, and treatment of bladder cancer.
BACKGROUND AND OBJECTIVES: Although the incidence of bladder cancer among women is lower, they tend to more often have advanced disease at presentation with a more aggressive course. It is still unclear which factors are responsible for the poorer prognosis of bladder cancer in women. MATERIALS AND METHODS: Original papers and reviews from 2004 until 2022 were identified in a PubMed search and evaluated. RESULTS: Multiple factors are likely responsible for the different courses of bladder cancer in women versus men. In the literature, epidemiologic and clinical aspects are discussed. Furthermore, genetic and hormonal causes and the role of the urobiome have been the focus of discussion more recently. CONCLUSIONS: Earlier diagnosis and better surgical treatment could lead to a more favorable course of bladder cancer in women. Further analyses of genetic, hormonal, und microbiological factors could open new perspectives in the prevention, diagnosis, and treatment of bladder cancer.
Authors: Georgios Gakis; Harman M Bruins; Richard Cathomas; Eva M Compérat; Nigel C Cowan; Antoine G van der Heijden; Virginia Hernández; Estefania E Linares Espinós; Anja Lorch; Yann Neuzillet; Maria J Ribal; Mathieu Rouanne; George N Thalmann; Erik Veskimäe; Alfred J Witjes Journal: Eur Urol Oncol Date: 2020-06-27
Authors: Marcus George Kwesi Cumberbatch; Ibrahim Jubber; Peter C Black; Francesco Esperto; Jonine D Figueroa; Ashish M Kamat; Lambertus Kiemeney; Yair Lotan; Karl Pang; Debra T Silverman; Ariana Znaor; James W F Catto Journal: Eur Urol Date: 2018-09-26 Impact factor: 20.096
Authors: Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan Journal: Eur Urol Date: 2012-07-25 Impact factor: 20.096
Authors: Karim Chamie; Mark S Litwin; Jeffrey C Bassett; Timothy J Daskivich; Julie Lai; Jan M Hanley; Badrinath R Konety; Christopher S Saigal Journal: Cancer Date: 2013-06-04 Impact factor: 6.860
Authors: Jakub Dobruch; Siamak Daneshmand; Margit Fisch; Yair Lotan; Aidan P Noon; Matthew J Resnick; Shahrokh F Shariat; Alexandre R Zlotta; Stephen A Boorjian Journal: Eur Urol Date: 2015-09-04 Impact factor: 20.096
Authors: Joep J de Jong; Joost L Boormans; Bas W G van Rhijn; Roland Seiler; Stephen A Boorjian; Badrinath Konety; Trinity J Bivalacqua; Thomas Wheeler; Robert S Svatek; James Douglas; Jonathan Wright; Marc Dall'Era; Simon J Crabb; Jason A Efstathiou; Michiel S van der Heijden; Kent W Mouw; David T Miyamoto; Yair Lotan; Peter C Black; Ewan A Gibb; Sima P Porten Journal: Eur Urol Oncol Date: 2020-03-20